Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 205837
Company: UCB INC

• Medication Guide

Products on NDA 205837

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
BRIVIACT	BRIVARACETAM	50MG/5ML (10MG/ML)	SOLUTION;INTRAVENOUS	Prescription	AP	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 205837

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes
02/18/2016	ORIG-1	Approval	Type 3 - New Dosage Form	STANDARD	Federal Register Notice Label (PDF) Letter (PDF) Review	FR Notice on DEA Scheduling; Date of Approval – May 12, 2016

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note
08/28/2025	SUPPL-14	Labeling-Medication Guide, Labeling-Package Insert	Label (PDF) Letter (PDF)
05/17/2023	SUPPL-11	Labeling-Medication Guide, Labeling-Package Insert	Label (PDF) Letter (PDF)
09/02/2021	SUPPL-9	Labeling-Container/Carton Labels, Labeling-Package Insert, Labeling-Medication Guide	Label (PDF) Letter (PDF)
08/27/2021	SUPPL-7	Efficacy-New Patient Population	Label (PDF) Letter (PDF)
05/10/2018	SUPPL-4	Labeling-Package Insert	Label (PDF) Letter (PDF)
09/14/2017	SUPPL-3	Efficacy-New Patient Population	Label (PDF) Letter (PDF)
06/03/2016	SUPPL-1	Labeling-Package Insert	Label (PDF) Letter (PDF)

Labels for NDA 205837

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note
08/28/2025	SUPPL-14	Labeling-Medication Guide	Label (PDF)
08/28/2025	SUPPL-14	Labeling-Package Insert	Label (PDF)
05/17/2023	SUPPL-11	Labeling-Medication Guide	Label (PDF)
05/17/2023	SUPPL-11	Labeling-Package Insert	Label (PDF)
09/02/2021	SUPPL-9	Labeling-Container/Carton Labels	Label (PDF)
09/02/2021	SUPPL-9	Labeling-Package Insert	Label (PDF)
09/02/2021	SUPPL-9	Labeling-Medication Guide	Label (PDF)
08/27/2021	SUPPL-7	Efficacy-New Patient Population	Label (PDF)
05/10/2018	SUPPL-4	Labeling-Package Insert	Label (PDF)
09/14/2017	SUPPL-3	Efficacy-New Patient Population	Label (PDF)
06/03/2016	SUPPL-1	Labeling-Package Insert	Label (PDF)
02/18/2016	ORIG-1	Approval	Label (PDF)

Therapeutic Equivalents for NDA 205837

BRIVIACT

SOLUTION;INTRAVENOUS; 50MG/5ML (10MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BRIVARACETAM	BRIVARACETAM	50MG/5ML (10MG/ML)	SOLUTION;INTRAVENOUS	Prescription	No	AP	218249	HAINAN POLY
BRIVARACETAM	BRIVARACETAM	50MG/5ML (10MG/ML)	SOLUTION;INTRAVENOUS	Prescription	No	AP	214880	MICRO LABS
BRIVARACETAM	BRIVARACETAM	50MG/5ML (10MG/ML)	SOLUTION;INTRAVENOUS	Prescription	No	AP	214924	MSN
BRIVIACT	BRIVARACETAM	50MG/5ML (10MG/ML)	SOLUTION;INTRAVENOUS	Prescription	Yes	AP	205837	UCB INC